AstraZeneca PLC AZN.L

GB · London Stock Exchange · XLON · stock · Healthcare · website

AstraZeneca PLC statistics & valuation

Market cap$218.7B

P / E21.4×

P / S3.7×

P / B4.5×

P / FCF25.2×

Dividend yield2.27%

Net margin17.4%

Return on equity21.0%

FCF margin14.8%

Multiples are price-derived and refreshed daily; everything else is from filings.

P / E vs its own history

AstraZeneca PLC trades at about 2156× earnings — below its 10-year norm (10-year range 2079.5×–5019×, median 2755.9×).

2079.5× 5019×

Shaded band = 10-year range (2079.5×–5019×); dot = today's 2156×.

Historical P/E = month-end price near each fiscal year-end ÷ that year's EPS. A read on whether the stock is cheap or dear relative to how it has typically been valued — not a forecast.

Key ratios (by fiscal year)

Ratio	FY2025	FY2024	FY2023	FY2022
Gross margin	81.9%	81.1%	82.0%	72.1%
Operating margin	22.7%	19.0%	19.0%	10.2%
Net margin	17.4%	13.0%	13.0%	7.4%
FCF margin	14.8%	13.5%	14.3%	16.3%
Return on assets	9.0%	6.8%	5.9%	3.4%
Return on equity	21.0%	17.2%	15.2%	8.9%
Debt / equity	0.51×	0.65×	0.57×	0.62×
Current ratio	0.94	0.93	0.82	0.86

Source: company filings via Yahoo Finance · GB · as of 2025-12-31. Figures in GBp; non-US fundamentals are aggregated by Yahoo (shorter history); facts plus Stocktoria's own computed scores — not investment advice.